Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells

Current Pharmaceutical Biotechnology

Volumn 12, Issue 2, 2011, Pages 160-170

  Katoh, Masaru ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

CXCR4; Gastric cancer; GlI1; HES1; JAG2; Pancreatic cancer; Peritoneal dissemination; WNT2B

Indexed keywords

ACTIVIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; DISHEVELLED PROTEIN; FRIZZLED PROTEIN; NOTCH RECEPTOR; PROTEIN NODAL; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER STEM CELL; CELL INTERACTION; CELL INVASION; EMBRYONIC STEM CELL; EPIGENETICS; GERM LINE; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGENERATIVE MEDICINE; SOMATIC MUTATION; UPREGULATION;

ERINACEIDAE; GASTROPODA;

EID: 79551631724     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794295710     Document Type: Article

References (120)

1. Katoh, M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev., 2007, 3, 30-38.
2. Gregorieff, A.; Pinto, D.; Begthel, H.; Destrée, O.; Kielman, M.; Clevers, H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology, 2005, 129, 626-638.
3. Nusse, R. Wnt signaling and stem cell control. Cell Res., 2008, 18, 523-527.
4. Chien, A. J.; Conrad, W. H.; Moon, R. T. A Wnt survival guide: from flies to human disease. J. Invest. Dermatol., 2009, 129, 1614-1627.
5. Katoh, M.; Katoh, M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res., 2007, 13, 4042-4045.
6. Dailey, L.; Ambrosetti, D.; Mansukhani, A.; Basilico, C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev., 2005, 16, 233-247.
7. Katoh, M. FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies. J. Invest. Dermatol., 2009, 129, 1862-1867.
8. Bae, J. H.; Schlessinger, J. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases. Mol. Cells, 2010, 29, 443-448.
9. Radtke, F.; Raj, K. The role of Notch in tumorigenesis: Oncogene or tumor suppressor? Nat. Rev. Cancer, 2003, 3, 765-767.
10. Leong, K. G.; Karsan A. Recent insight into the role of Notch signaling in tumorigenesis. Blood, 2006, 107, 2223-2233.
11. Katoh, M.; Katoh, M. Notch signaling in gastrointestinal tract. Int. J. Oncol., 2007, 30, 247-251.
12. Moustakas, A.; Heldin, C. H. Dynamic control of TGF β signaling and its links to the cytoskeleton. FEBS Lett., 2008, 582, 2051-2065.
13. Massagué, J. TGFβ in cancer. Cell, 2008, 134, 215-230.
14. Lum, L.; Beachy, P. A. The Hedgehog response network: sensors, switches, and routers. Science, 2004, 304, 1755-1759.
15. Katoh, Y.; Katoh, M. Hedgehog signaling in gastric cancer. Cancer Biol. Ther., 2005, 4, 1050-1054.
16. Vokes, S. A.; Ji, H.; Wong, W. H.; McMahon, A.P. A genomescale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev., 2008, 22, 2651-2663.
17. Wilson, C. W.; Chuang, P. T. Mechanism and evolution of cytosolic Hedgehog signal transduction. Development, 2010, 137, 2079-2094.
18. Katoh, M. WNT and FGF gene clusters. Int. J. Oncol., 2002, 21, 1269-1273.
19. Nusse, R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development, 2003, 130, 5297-5305.
20. Hausmann, G.; Bänziger, C.; Basler, K. Helping Wingless take flight: how WNT proteins are secreted. Nat. Rev. Mol. Cell Biol., 2007, 8, 331-336.
21. Koike, J.; Takagi, A.; Miwa, T.; Hira,i M.; Terada, M.; Katoh, M. Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem. Biophys. Res. Commun., 1999, 262, 39-43.
22. Lagerström, M. C.; Schiöth, H. B. Structural diversity of G proteincoupled receptors and significance for drug discovery. Nat. Rev. Drug Discov., 2008, 7, 339-357.
23. Rey, J. P.; Ellies, D. L. Wnt modulators in the biotech pipeline. Dev. Dyn., 2010, 239, 102-114.
24. Fan, X. S.; Wu, H. Y.; Yu, H. P.; Zhou, Q.; Zhang, Y. F.; Huang, Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with β-catenin. Int. J. Colorectal Dis., 2010, 25, 583-590.
25. Fukuda, T.; Chen, L.; Endo, T.; Tang, L.; Lu, D.; Castro, J. E.; Widhopf, G. F2nd.; Rassenti, L. Z.; Cantwell, M. J.; Prussak, C. E.; Carson, D. A.; Kipps, T. J. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc. Natl. Acad. Sci. USA, 2008, 105, 3047-3052.
26. O'Connell, M. P.; Weeraratna, A.T. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt. Pig. Cell Melanoma Res., 2009, 22, 724-739.
27. Minami, Y.; Oishi, I.; Endo, M.; Nishita, M. Ror-family receptor tyrosine kinases in non-canonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev. Dyn., 2010, 239, 1-15.
28. Hirata, H.; Hinoda, Y.; Ueno, K.; Majid, S.; Saini, S.; Dahiya, R. Role of secreted frizzled-related protein 3 in human renal cell carcinoma. Cancer Res., 2010, 70, 1896-1905.
29. Reins, J.; Mossner, M.; Neumann, M.; Platzbecker, U.; Schumann, C.; Thiel, E.; Hofmann, W.K. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS. Leuk. Res., 2010, 34(12), 1610-1616.
30. Yamamoto, S.; Nishimura, O.; Misaki, K.; Nishita, M.; Minami, Y.; Yonemura, S.; Tarui, H.; Sasaki, H. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell, 2008, 15, 23-36.
31. Mikels, A. J.; Nusse, R. Wnts as ligands: processing, secretion and reception. Oncogene, 2006, 25, 7461-7468.
32. Angers, S.; Moon, R.T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol., 2009, 10, 468-477.
33. Morin, P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinzler, K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 1997, 275, 1787-1790.
34. Barker, N.; Clevers, H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov., 2006, 5, 997-1014.
35. Huber, A. H.; Nelson, W. J.; Weis, W.I. Three-dimensional structure of the armadillo repeat region of β-catenin. Cell, 1997, 90, 871-882.
36. Coates, J. C. Armadillo repeat proteins: beyond the animal kingdom. Trends Cell Biol., 2003, 13, 463-471.
37. Mosimann, C.; Hausmann, G.; Basler, K. β-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol., 2009, 10, 276-286.
38. Kimelman, D.; Xu, W. β-catenin destruction complex: insights and questions from a structural perspective. Oncogene, 2006, 25, 7482-7491.
39. Verheyen, E. M.; Gottardi, C.J. Regulation of Wnt/β-catenin signaling by protein kinases. Dev. Dyn., 2010, 239, 34-44.
40. Koike, J.; Sagara, N.; Kirikoshi, H.; Takagi, A.; Miwa, T.; Hirai, M.; Katoh, M. Molecular cloning and genomic structure of the βTRCP2 gene on chromosome 5q35.1. Biochem. Biophys. Res. Commun., 2000, 269, 103-109.
41. Spiegelman, V. S.; Tang, W.; Katoh, M.; Slaga, T. J.; Fuchs, S. Y. Inhibition of HOS expression and activities by Wnt pathway. Oncogene, 2002, 21, 856-860.
42. Frescas, D.; Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat. Rev. Cancer, 2008, 8, 438-449.
43. Wong, H. C.; Bourdelas, A.; Krauss, A.; Lee, H. J.; Shao, Y.; Wu, D.; Mlodzik, M.; Shi, D. L.; Zheng, J. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the Cterminal region of Frizzled. Mol. Cell, 2003, 12, 1251-1260.
44. Tolwinski, N. S.; Wehrli, M.; Rives, A.; Erdeniz, N.; DiNardo, S.; Wieschaus, E. Wg/Wnt signal can be transmitted through arrow/ LRP5,6 and Axin independently of Zw3/Gsk3β activity. Dev. Cell, 2003, 4, 407-418.
45. Sagara, N.; Toda, G.; Hirai, M.; Terada, M.; Katoh, M. Molecular cloning, differential expression, and chromosomal localization of human Frizzled-1, Frizzled-2, and Frizzled-7. Biochem. Biophys. Res. Commun., 1998, 252, 117-122.
46. Willert, J.; Epping, M.; Pollack, J. R.; Brown, P. O.; Nusse, R.A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol., 2002, 2, 8.
47. Chamorro, M. N.; Schwartz, D. R.; Vonica, A.; Brivanlou, A. H.; Cho, K. R.; Varmus, H. E. FGF20 and DKK1 are transcriptional targets of β-catenin and FGF20 is implicated in cancer and development. EMBO J., 2005, 24, 73-84.
48. Spiegelman, V. S.; Slaga, T. J.; Pagano, M.; Minamoto, T.; Ronai, Z.; Fuchs, S.Y. Wnt/β-catenin signaling induces the expression and activity of βTrCP ubiquitin ligase receptor. Mol. Cell, 2000, 5, 877-882.
49. Kirikoshi, H.; Sekihara, H.; Katoh, M. Molecular cloning and characterization of human WNT11. Int. J. Mol. Med., 2001, 8, 651-656.
50. Lin, L.; Cui, L.; Zhou, W.; Dufort, D.; Zhang, X.; Cai, C.L.; Bu, L.; Yang, L.; Martin, J.; Kemler, R.; Rosenfeld, M. G.; Chen, J.; Evans, S. M. β-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis. Proc. Natl. Acad. Sci. USA, 2007, 104, 9313-9318.
51. He, T. C.; Sparks, A. B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L. T.; Morin, P. J.; Vogelstein, B.; Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281, 1509-1512.
52. Tetsu, O.; McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398, 422-426.
53. Kirikoshi, H.; Sagara, N.; Saitoh, T.; Tanaka, K.; Sekihara, H.; Shiokawa, K.; Katoh, M. Molecular cloning and characterization of human FGF20 on chromosome 8p21.3-p22. Biochem. Biophys. Res. Commun., 2000, 274, 337-343.
54. Katoh, M.; Katoh, M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med., 2006, 17, 681-685.
55. Sekiya, T.; Adachi, S.; Kohu, K.; Yamada, T.; Higuchi, O.; Furukawa, Y.; Nakamura, Y.; Nakamura, T.; Tashiro, K.; Kuhara, S.; Ohwada, S.; Akiyama, T. Identification of BAMBI, an inhibitor of TGFβ signaling, as a target of the β-catenin pathway in colorectal tumor cells. J. Biol. Chem., 2004, 279, 6840-6846.
56. Veeman, M. T.; Axelrod, J. D.; Moon, R. T. A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell, 2003, 5, 367-377.
57. Katoh, M. WNT/PCP signaling pathway and human cancer. Oncol. Rep., 2005, 14, 1583-1588.
58. Witze, E. S.; Litman, E. S.; Argast, G. M.; Moon, R. T.; Ahn, N. G. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science, 2008, 320, 365-369.
59. Zhang, X.; Zhu, J.; Yang, G. Y.; Wang, Q. J.; Qian, L.; Chen, Y. M.; Chen, F.; Tao, Y.; Hu, H. S.; Wang, T.; Luo, Z. G. Dishevelled promotes axon differentiation by regulating aPKC. Nat. Cell Biol., 2007, 9, 743-754.
60. Dejmek, J.; Säfholm, A.; Kamp Nielsen, C.; Andersson, T.; Leandersson, K. Wnt5a/Ca2+-induced NFAT activity is counteracted by Wnt5a/Yes-Cdc42-CK1β signaling in human mammary epithelial cells. Mol. Cell. Biol., 2006, 26, 6024-6036.
61. Ishitani, T.; Ninomiya-Tsuji, J.; Nagai, S.; Nishita, M.; Meneghini, M.; Barker, N.; Waterman, M.; Bowerman, B.; Clevers, H.; Shibuya, H.; Matsumoto, K. The TAK1-NLK pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature, 1999, 399, 798-802.
62. Wang, Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol. Cancer Ther., 2009, 8, 2103-2109.
63. Dissanayake, S. K.; Wade, M.; Johnson, C. E.; O'Connell, M. P.; Leotlela, P. D.; French, A. D.; Shah, K. V.; Hewitt, K. J.; Rosenthal, D.T.; Indig, F. E.; Jiang, Y.; Nickoloff, B. J.; Taub, D. D.; Trent, J. M.; Moon, R. T.; Bittner, M.; Weeraratna, A. T. The Wnt5A/PKC pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of EMT. J. Biol. Chem., 2007, 282, 17259-17271.
64. Jr., Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev. Biol., 2003, 253, 1-17.
65. Higgs, H. N. Formin proteins: a domain-based approach. Trends Biochem. Sci., 2005, 30, 342-353.
66. Ju, R.; Cirone, P.; Lin, S.; Griesbach, H.; Slusarski, D. C.; Crews, C. M. Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis. Proc. Natl. Acad. Sci. USA, 2010, 107, 6906-6911.
67. Slusarski, D. C.; Corces, V. G.; Moon, R. T. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature, 1997, 390, 410-413.
68. Delaney, J. R.; Mlodzik, M. TGF-β activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle, 2006, 5, 2852-2855.
69. Adhikari, A.; Xu, M.; Chen, Z. J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene, 2007, 26, 3214-3226.
70. Thakur, N.; Sorrentino, A.; Heldin, C. H.; Landström, M. TGF-β uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells. Future Oncol., 2009, 5, 1-3.
71. Ishitani, T.; Hirao, T.; Suzuki, M.; Isoda, M.; Ishitani, S.; Harigaya, K.; Kitagawa, M.; Matsumoto, K.; Itoh, M. Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat. Cell Biol., 2010, 12, 278-285.
72. Takada, I.; Mihara, M.; Suzawa, M.; Ohtake, F.; Kobayashi, S.; Igarashi, M.; Kato, S. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-β transactivation. Nat. Cell Biol., 2007, 9, 1273-1285.
73. Karin, M. The IβB kinase: a bridge between inflammation and cancer. Cell Res., 2008, 18, 334-342.
74. Shackleford, G. M.; MacArthur, C. A.; Kwan, H. C.; Varmus, H. E. MMTV infection accelerates mammary carcinogenesis in Wnt1 transgenic mice by insertional activation of Fgf3 and Fgf4. Proc. Natl. Acad. Sci. USA, 1993, 90, 740-744.
75. Lee, F. S.; Lane, T. F.; Kuo, A.; Shackleford, G. M.; Leder, P. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of Fgf3 transgenic mice. Proc. Natl. Acad. Sci. USA, 1995, 92, 2268-2272.
76. Callahan, R.; Smith, G. H. Common integration sites for MMTV in viral induced mouse mammary tumors. J. Mammary Gland Biol. Neoplasia, 2008, 13, 309-321.
77. Shimokawa, T.; Furukawa, Y.; Sakai, M.; Li, M.; Miwa, N.; Lin, Y. M.; Nakamura, Y. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the β-catenin/TCF complex. Cancer Res., 2003, 63, 6116-6120.
78. Pai, R.; Dunlap, D.; Qing, J.; Mohtashemi, I.; Hotzel, K.; French, D. M. Inhibition of FGF19 reduces tumor growth by modulating β- catenin signaling. Cancer Res., 2008, 68, 5086-5095.
79. Pond, A. C.; Herschkowitz, J. I.; Schwertfeger, K. L.; Welm, B.; Zhang, Y.; York, B.; Cardiff, R. D.; Hilsenbeck, S.; Perou, C. M.; Creighton, C. J.; Lloyd, R. E.; Rosen, J. M. FGF receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the MMTV-Wnt1 mouse model of breast cancer. Cancer Res., 2010, 70, 4868-4679.
80. Shen, L.; Zhou, S.; Glowacki, J. Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J. Cell. Biochem., 2009, 106, 337-343.
81. Trubiani, O.; Zalzal, S. F.; Paganelli, R.; Marchisio, M.; Giancola, R.; Pizzicannella, J.; Bühring, H. J.; Piattelli, M.; Caputi, S.; Nanci, A. Expression profile of the embryonic markers Nanog, Oct-4, SSEA-1, SSEA-4 and FRIZZLED-9 receptor in human periodontal ligament mesenchymal stem cells. J. Cell. Physiol., 2010, 225(1), 123-131.
82. Maruyama, T.; Mirando, A. J.; Deng, C. X.; Hsu, W. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal., 2010, 3, ra40.
83. Ross, S. E.; Hemati, N.; Longo, K. A.; Bennett, C. N.; Lucas, P. C.; Erickson, R. L.; MacDougald, O. A. Inhibition of adipogenesis by Wnt signaling. Science, 2000, 289, 950-953.
84. Gustafson, B.; Smith, U. Activation of canonical Wnt signaling in mature adipocytes increases β-catenin levels and leads to cell dedifferentiation and insulin resistance. J. Biol. Chem., 2010, 285, 14031-14041.
85. Raucci, A.; Bellosta, P.; Grassi, R.; Basilico, C.; Mansukhani, A. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell. Physiol., 2008, 215, 442-451.
86. Asaki, T.; Konishi, M.; Miyake, A.; Kato, S.; Tomizawa, M.; Itoh, N. Roles of Fgf10 in adipogenesis in vivo. Mol. Cell. Endocrinol., 2004, 218, 119-128.
87. Cheyette, B. N.; Waxman, J. S.; Miller, J. R.; Takemaru, K.; Sheldahl, L. C.; Khlebtsova, N.; Fox, E. P.; Earnest, T.; Moon, R. T. Dapper, a Dishevelled-associated antagonist of β-catenin and JNK signaling, is required for notochord formation. Dev. Cell, 2002, 2, 449-461.
88. Katoh, M.; Katoh, M. Identification and characterization of human DAPPER1 and DAPPER2 genes in silico. Int. J. Oncol., 2003, 22, 907-913.
89. Suriben, R.; Fisher, D. A.; Cheyette, B. N. Dact1 presomitic mesoderm expression oscillates in phase with Axin2 in the somitogenesis clock of mice. Dev. Dyn., 2006, 235, 3177-3183.
90. Estrach, S.; Ambler, C. A.; Lo Celso, C.; Hozumi, K.; Watt, F. M. Jag1 is a β-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development, 2006, 133, 4427-4438.
91. Greber, B.; Lehrach, H.; Adjaye, J. Control of early fate decisions in human ES cells by distinct states of TGFβ pathway activity. Stem Cells Dev., 2008, 17, 1065-1077.
92. Roarty, K.; Serra, R. Wnt5a is required for proper mammary gland development and TGFβ-mediated inhibition of ductal growth. Development, 2007, 134, 3929-3939.
93. Seki, K.; Hata, A. Ihh gene is a target of the BMP signaling pathway. J. Biol. Chem., 2004, 279, 18544-18549.
94. Yoon, J. W.; Kita, Y.; Frank, D. J.; Majewski, R. R.; Konicek, B. A.; Nobrega, M. A.; Jacob, H.; Walterhouse, D.; Iannaccone, P. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem., 2002, 277, 5548-5555.
95. Kasper, M.; Schnidar, H.; Neill, G. W.; Hanneder, M.; Klingler, S.; Blaas, L.; Schmid, C.; Hauser-Kronberger, C.; Regl, G.; Philpott, M. P.; Aberger, F. Selective modulation of Hedgehog/GLI target gene expression by EGF signaling in human keratinocytes. Mol. Cell. Biol., 2006, 26, 6283-6298.
96. Hallikas, O.; Palin, K.; Sinjushina, N.; Rautiainen, R.; Partanen, J.; Ukkonen, E.; Taipale, J. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell, 2006, 124, 47-59.
97. Katoh, Y.; Katoh, M. WNT antagonist, SFRP1, is Hedgehog signaling target. Int. J. Mol. Med., 2006, 17, 171-175.
98. Katoh, Y.; Katoh, M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr. Mol. Med., 2009, 9, 873-886.
99. van den Brink, G. R.; Bleuming, S. A.; Hardwick, J. C.; Schepman, B. L.; Offerhaus, G. J.; Keller, J. J.; Nielsen, C.; Gaffield, W.; van Deventer, S. J.; Roberts, D. J.; Peppelenbosch, M. P. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat. Genet., 2004, 36, 277-282.
100. Yoo, Y. A.; Kang, M. H.; Kim, J. S.; Oh, S. C. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGFβ-mediated activation of the ALK5-Smad3 pathway. Carcinogenesis, 2008, 29, 480-490.
101. G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 1981, 78, 7634-7638.
102. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282, 1145-1147.
103. Tesar, P. J.; Chenoweth, J. G.; Brook, F. A.; Davies, T. J.; Evans, E. P.; Mack, D. L.; Gardner, R. L.; McKay, R. D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, 2007, 448, 196-199.
104. Yu, J.; Thomson, J. A. Pluripotent stem cell lines. Genes Dev., 2008, 22, 1987-1997.
105. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676.
106. Park, I. H.; Zhao, R.; West, J. A.; Yabuuchi, A.; Huo, H.; Ince, T. A.; Lerou, P. H.; Lensch, M. W.; Daley, G. Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008, 451, 141-146.
107. Chin, M. H.; Mason, M. J.; Xie, W.; Volinia, S.; Singer, M.; Peterson, C.; Ambartsumyan, G.; Aimiuwu, O.; Richter, L.; Zhang, J.; Khvorostov, I.; Ott, V.; Grunstein, M.; Lavon, N.; Benvenisty, N.; Croce, C. M.; Clark, A. T.; Baxter, T.; Pyle, A. D.; Teitell, M. A.; Pelegrini, M.; Plath, K.; Lowry, W. E. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 2009, 5, 111-123.
108. Feng, B.; Ng, J. H.; Heng, J. C.; Ng, H. H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 2009, 4, 301-312.
109. Marson, A.; Foreman, R.; Chevalier, B.; Bilodeau, S.; Kahn, M.; Young, R. A.; Jaenisch, R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell, 2008, 3, 132-135.
110. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 2003, 113, 631-642.
111. Cole, M. F.; Johnstone, S. E.; Newman, J. J.; Kagey, M. H.; Young, R. A. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev., 2008, 22, 746-755.
112. Li, W.; Wei, W.; Zhu, S.; Zhu, J.; Shi, Y.; Lin, T.; Hao, E.; Hayek, A.; Deng, H.; Ding, S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 2009, 4, 16-19.
113. M. WNT signaling in stem cell biology and regenerative medicine. Curr. Drug Targets, 2008, 9, 565-570.
114. Bonnet, D.; Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med., 1997, 3, 730-737.
115. O'Brien, C. A.; Kreso, A.; Jamieson, C. H. Cancer stem cells and self-renewal. Clin. Cancer Res., 2010, 16, 3113-3120.
116. M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change, and genetic alteration in gastric cancer. Cancer Biol. Ther., 2007, 6, 832-839.
117. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J.W.; Guba, M.; Bruns, C. J.; Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 2007, 1, 313-323.
118. Berman, D. M.; Karhadkar, S. S.; Maitra, A.; Montes De Oca, R.; Gerstenblith, M. R.; Briggs, K.; Parker, A. R.; Shimada, Y.; Eshleman, J. R.; Watkins, D.N.; Beachy, P. A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature, 2003, 425, 846-851.
119. Katoh, M.; Katoh, M. Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFβ, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors. Int. J. Oncol., 2010, 36, 415-20.
120. Katoh, Y.; Katoh, M. Hedgehog signaling, epithelial-tomesenchymal transition, and miRNA. Int. J. Mol. Med., 2008, 22, 271-275.